O. Troum

733 total citations
26 papers, 569 citations indexed

About

O. Troum is a scholar working on Rheumatology, Surgery and Hematology. According to data from OpenAlex, O. Troum has authored 26 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Rheumatology, 6 papers in Surgery and 6 papers in Hematology. Recurrent topics in O. Troum's work include Rheumatoid Arthritis Research and Therapies (18 papers), Systemic Lupus Erythematosus Research (6 papers) and Spondyloarthritis Studies and Treatments (6 papers). O. Troum is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (18 papers), Systemic Lupus Erythematosus Research (6 papers) and Spondyloarthritis Studies and Treatments (6 papers). O. Troum collaborates with scholars based in United States, United Kingdom and Denmark. O. Troum's co-authors include John V. Crues, Philip G. Conaghan, Corrado Bernasconi, Howard Amital, T. Huizinga, Ricardo Machado Xavier, Georg Schett, Maxime Dougados, K. Kissel and E. Martín‐Mola and has published in prestigious journals such as Clinical Orthopaedics and Related Research, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

O. Troum

23 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
O. Troum United States	11	485	184	115	102	93	26	569
Laure Brulhart Switzerland	11	461 1.0×	167 0.9×	117 1.0×	56 0.5×	100 1.1×	22	526
Mirjam K. de Vries Netherlands	8	409 0.8×	108 0.6×	212 1.8×	88 0.9×	36 0.4×	8	537
L.E. Burgers Netherlands	16	617 1.3×	202 1.1×	126 1.1×	31 0.3×	79 0.8×	23	724
Fedra Irazoque-Palazuelos Mexico	10	464 1.0×	180 1.0×	155 1.3×	18 0.2×	115 1.2×	24	539
Xianhuang Zhou United States	5	262 0.5×	122 0.7×	68 0.6×	31 0.3×	73 0.8×	7	375
Peter A. H. M. van der Lubbe Netherlands	6	327 0.7×	116 0.6×	64 0.6×	37 0.4×	66 0.7×	7	382
Robin M. ten Brinck Netherlands	13	378 0.8×	110 0.6×	71 0.6×	38 0.4×	27 0.3×	19	460
Miguel Ángel Plasín Spain	5	281 0.6×	152 0.8×	95 0.8×	68 0.7×	31 0.3×	7	394
Breedveld Fc Netherlands	10	329 0.7×	129 0.7×	94 0.8×	37 0.4×	31 0.3×	17	438
Carlos Tolosa Spain	4	328 0.7×	182 1.0×	40 0.3×	54 0.5×	32 0.3×	15	416

Countries citing papers authored by O. Troum

Since Specialization

Citations

This map shows the geographic impact of O. Troum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Troum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Troum more than expected).

Fields of papers citing papers by O. Troum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Troum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Troum. The network helps show where O. Troum may publish in the future.

Co-authorship network of co-authors of O. Troum

This figure shows the co-authorship network connecting the top 25 collaborators of O. Troum. A scholar is included among the top collaborators of O. Troum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Troum. O. Troum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Troum, O., Mai Duong, K. Obermeyer, Lissa Padnick‐Silver, & Brian LaMoreaux. (2025). Treatment-emergent major adverse cardiovascular and thromboembolic events were infrequent during clinical trials of pegloticase. Lara D. Veeken. 64(6). 3328–3333.

Troum, O., et al.. (2024). Imaging in vasculitis. Current Opinion in Rheumatology. 37(1). 39–44. 2 indexed citations

Conaghan, Philip G., Mikkel Østergaard, O. Troum, et al.. (2019). Very early MRI responses to therapy as a predictor of later radiographic progression in early rheumatoid arthritis. Arthritis Research & Therapy. 21(1). 214–214. 21 indexed citations

Peterfy, Charles, Vibeke Strand, Lü Tian, et al.. (2016). Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trials. Annals of the Rheumatic Diseases. 76(6). 992–997. 14 indexed citations

Troum, O., Ewa Olech, Mikkel Østergaard, et al.. (2015). Proceedings from The 8th Annual International Society for Musculoskeletal Imaging in Rheumatology (ISEMIR) Conference. Seminars in Arthritis and Rheumatism. 45(6). e17–e23.

Troum, O., Wolfgang Schmidt, Mikkel Østergaard, et al.. (2015). Proceedings from the 7th Annual International Society for Musculoskeletal Imaging in Rheumatology (ISEMIR) conference. Seminars in Arthritis and Rheumatism. 45(1). 115–121. 1 indexed citations

Conaghan, Philip G., Charles Peterfy, Ewa Olech, et al.. (2014). The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy. Annals of the Rheumatic Diseases. 73(5). 810–816. 43 indexed citations

Dougados, Maxime, K. Kissel, Philip G. Conaghan, et al.. (2014). Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study. Annals of the Rheumatic Diseases. 73(5). 803–809. 112 indexed citations

Huizinga, T., Philip G. Conaghan, E. Martín‐Mola, et al.. (2014). Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study. Annals of the Rheumatic Diseases. 74(1). 35–43. 90 indexed citations

10.

Huizinga, T., Philip G. Conaghan, E. Martín‐Mola, et al.. (2014). SAT0255 Clinical and Radiographic Outcomes at 2 Years and the Effect of TOCILIZUMAB Discontinuation following Sustained Remission in the Second and Third Year of the ACT-RAY Study. Annals of the Rheumatic Diseases. 73. 685–685. 3 indexed citations

11.

Conaghan, Philip G., Mikkel Østergaard, Maria Antonietta D’Agostino, et al.. (2013). Proceedings from the 5th Annual International Society for Musculoskeletal Imaging in Rheumatology Annual Conference. Seminars in Arthritis and Rheumatism. 42(4). 433–446. 1 indexed citations

12.

Weaver, Arthur L., O. Troum, Michele Hooper, et al.. (2013). Rheumatoid Arthritis Disease Activity and Disability Affect the Risk of Serious Infection Events in RADIUS 1. The Journal of Rheumatology. 40(8). 1275–1281. 39 indexed citations

13.

Dougados, Maxime, K. Kissel, Philip G. Conaghan, et al.. (2012). Clinical, Radiographic, and Immunogenic Effects After 1 Year of Tocilizumab-Based Treatment Strategy with and without Methotrexate in Rheumatoid Arthritis: The ACT-RAY Study. Data Archiving and Networked Services (DANS). 64(10). 6 indexed citations

14.

Troum, O., et al.. (2012). Magnetic Resonance Imaging Applications in Early Rheumatoid Arthritis Diagnosis and Management. Rheumatic Disease Clinics of North America. 38(2). 277–297. 5 indexed citations

15.

Dougados, Maxime, K. Kissel, Philip G. Conaghan, et al.. (2012). THU0093 Clinical, radiographic, and immunogenic effects after 1 year of tocilizumab (TCZ)-based treatment strategy with and without methotrexate (MTX) in RA: The act-ray study. Annals of the Rheumatic Diseases. 71. 185–185. 7 indexed citations

16.

Dougados, Maxime, K. Kissel, Howard Amital, et al.. (2011). Double-Blind Study of Tocilizumab Plus Methotrexate Vs Tocilizumab Plus Placebo in Patients with Active Rheumatoid Arthritis Despite Prior Methotrexate : Progression of Structural Damage, Quality of Life, and Physical Function At 24 Weeks.. Data Archiving and Networked Services (DANS). 63(10). 28–29. 6 indexed citations

17.

Troum, O.. (2007). Newer Imaging Technology for the Diagnosis of Early RA and Monitoring of Inflammation and Joint Damage. JCR Journal of Clinical Rheumatology. 13(5). 280–284. 2 indexed citations

18.

Furst, D E, Norman Gaylis, Ewa Olech, et al.. (2007). Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study. Annals of the Rheumatic Diseases. 66(7). 893–899. 88 indexed citations

19.

Crues, John V., et al.. (2006). Magnetic resonance imaging is more sensitive than radiographs in detecting change in size of erosions in rheumatoid arthritis.. PubMed. 33(10). 1957–67. 23 indexed citations

20.

Troum, O. & John V. Crues. (2004). The Young Adult With Hip Pain: Diagnosis and Medical Treatment, Circa 2004. Clinical Orthopaedics and Related Research. 418(418). 9–17. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact